[Clinical experimentation of a new drug based on retinal lipids and phospholipids of the optic pathways in certain degenerative diseases of the retina].
D001161:Arteriosclerosis / Q000188:drug therapy; D002825:Chorioretinitis / Q000188:drug therapy*; D006801:Humans; D008055:Lipids / Q000627:therapeutic use; D010743:Phospholipids; D012160:Retina; D012162:Retinal Degeneration; D012163:Retinal Detachment / Q000188:drug therapy*; D012174:Retinitis Pigmentosa / Q000188:drug therapy*; D014020:Tissue Extracts / Q000627:therapeutic use
D008055:Lipids; D010743:Phospholipids; D014020:Tissue Extracts
Sperimentazione clinica di un nuovo farmaco a base di lipidi retinici e fosfolipidi delle vie ottiche in alcune affezioni degenerative della retina.